176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-46.40%
Negative revenue growth while INTC stands at 12.57%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-61.49%
Negative gross profit growth while INTC is at 26.57%. Joel Greenblatt would examine cost competitiveness or demand decline.
-408.27%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-408.27%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-339.14%
Negative net income growth while INTC stands at 22.95%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-346.43%
Negative EPS growth while INTC is at 23.53%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-342.86%
Negative diluted EPS growth while INTC is at 21.21%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.13%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.67%
Reduced diluted shares while INTC is at 0.61%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-146.15%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
4.83%
Positive FCF growth while INTC is negative. John Neff would see a strong competitive edge in net cash generation.
214.06%
10Y revenue/share CAGR above 1.5x INTC's 55.52%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-8.16%
Negative 5Y CAGR while INTC stands at 25.49%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-21.22%
Negative 3Y CAGR while INTC stands at 13.76%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-413.82%
Negative 10Y OCF/share CAGR while INTC stands at 20.13%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-1784.49%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-109.14%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-947.67%
Negative 10Y net income/share CAGR while INTC is at 30.81%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-650.66%
Negative 5Y net income/share CAGR while INTC is 22.49%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-256.25%
Negative 3Y CAGR while INTC is 58.64%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1510.75%
10Y equity/share CAGR above 1.5x INTC's 54.89%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
105.29%
5Y equity/share CAGR above 1.5x INTC's 23.19%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
70.43%
3Y equity/share CAGR above 1.5x INTC's 18.40%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.61%
Firm’s AR is declining while INTC shows 12.25%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.64%
Inventory shrinking or stable vs. INTC's 17.87%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-8.17%
Negative asset growth while INTC invests at 4.12%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.61%
We have a declining book value while INTC shows 7.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.27%
Our R&D shrinks while INTC invests at 12.10%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.33%
We cut SG&A while INTC invests at 105.91%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.